The Department of Health Care Access and Information (HCAI) is pleased to announce the Data Analytics Public Reporting Plan for 2023, which is a list of the analytics products HCAI plans to publish. The table below lists the measure, topic area, and the quarter which HCAI is projecting product release.
| HCAI Topic Area | Measure | 2023 End Date |
| Healthcare Quality | Mental and Behavioral Health Diagnoses in Emergency Department and Inpatient Discharges by Healthy Places Index Ranking | Q1 2023 |
| Healthcare Utilization | Emergency Department Volume and Capacity by Facility, Health Category and Health Professional Shortage Area | Q1 2023 |
| Healthcare Quality | Pediatric Quality Indicators (PDIs)- Area Level 14 Asthma Admission Rate, 16 Gastroenteritis Admission Rate, 18 Urinary Tract Infection Admission Rate, 90 Pediatric Quality Overall Composite (area level) | Q1 2023 |
| Healthcare Quality | Preventable Hospitalizations for Chronic Conditions | Q2 2023 |
| Cost Transparency | Wholesale Acquisition Cost (WAC) Increase Report Data – Current Year | Q1 2023 |
| Cost Transparency | Wholesale Acquisition Cost (WAC) Increase Report Data – Cumulative | Q1 2023 |
| Cost Transparency | Prescription Drugs Introduced to Market | Q1 2023 |
| Healthcare Quality | Effects of COVID-19 on Hospital Utilization Trends | Q1 2023 |
| Healthcare Quality | Inpatient Mortality Indicators | Q2 2023 |
| Healthcare Utilization | Inpatient Hospitalizations and Emergency Department Visits for Patients with a Behavioral Health Diagnosis in California: Patient Demographics | Q2 2023 |
| Healthcare Quality | Social Drivers of Health (SDoH) and Preventable Hospitalization Rates, 2020 | Q2 2023 |
| Healthcare Utilization | California Diagnostic Catheterization Volume and Sociodemographic Comparisons | Q2 2023 |
| Healthcare Quality | Preventable Hospitalizations for Acute Conditions | Q2 2023 |
| Cost Transparency | Hospital Financial Data Interactive Series: Hospital Average Cost and Profitability Delivering Patient Care | Q2 2023 |
| Cost Transparency | Hospital Financial Data Interactive Series: Hospital Financials | Q2 2023 |
| Cost Transparency | Hospital Financial Data Interactive Series: Hospital Utilization | Q2 2023 |
| Healthcare Quality | Hospital Performance Ratings Summary | Q2 2023 |
| Healthcare Quality | Readmissions for Isolated Coronary Artery Bypass Graft (CABG) Complications | Q2 2023 |
| Healthcare Utilization | Preferred Languages Spoken in California Facilities | Q3 2023 |
| Healthcare Quality | Coronary Artery Bypass Graft: Hospital Performance Ratings, 2021 | Q3 2023 |
| Cost Transparency | Chronic Conditions, Hospital Utilization, and Other Characteristics of Insured Californians (HPD) | Q3 2023 |
| Cost Transparency | Healthcare Payments Data (HPD) Snapshot | Q3 2023 |
| Healthcare Quality | Elective Percutaneous Coronary Intervention (PCI) Program Reports, 2022 | Q4 2023 |
| Cost Transparency | Pharmaceutical Cost (HPD) | Q4 2023 |
| Healthcare Quality | Maternity Care Honor Roll, 2023 | Q4 2023 |
| Healthcare Utilization | Facility Patient Flow: Where Did Patients Come From, How Long Did They Stay and Where Did They Go? | Q4 2023 |
| Healthcare Quality | Hospitalizations for Severe Sepsis in California | Q4 2023 |
| Healthcare Quality | AHRQ utilizations (IQI 21, IQI 22, and IQI33) | Q4 2023 |
In addition to the products listed above, HCAI is also exploring the below list as “stretch goals” to release during 2023, if feasible.
To provide comments or to submit a question regarding the 2023 Analytic Plan please contact DataAndReports@hcai.ca.gov
